C, A., M, H., JF, J., & F, S. (2026). Biologics in Kidney Transplantation: Why and How Should We Personalize Their Dosage? BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 40(4), 693. https://doi.org/10.1007/s40259-026-00790-0
Chicago Style (17th ed.) CitationC, Arrivé, Hotot M, Jourdil JF, and Stanke-Labesque F. "Biologics in Kidney Transplantation: Why and How Should We Personalize Their Dosage?" BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy 40, no. 4 (2026): 693. https://doi.org/10.1007/s40259-026-00790-0.
MLA (9th ed.) CitationC, Arrivé, et al. "Biologics in Kidney Transplantation: Why and How Should We Personalize Their Dosage?" BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, vol. 40, no. 4, 2026, p. 693, https://doi.org/10.1007/s40259-026-00790-0.